Skip to main content
. 2020 Jun 18;13:1873–1880. doi: 10.2147/IDR.S241948

Table 4.

De-Novo Occurrence of HCC After Treatment in SVR and Non-SVR Patients

SVR (n= 329) Non-SVR (n= 21) P-value
Mean ± SD Mean ± SD
PCR 0.768
 Median 550,000 483,000
 Range 52–815,000,000 13,000–474,000,000
HCC after treatment 0.016*
 Yes 22 (6.7%) 5 (23.8%)
 No 307 (93.3%) 16 (76.2%)

Note: *Significant.

Abbreviations: SVR, sustained virological response; HCC, hepatocellular carcinoma.